Antofagasta PLC (LON:ANTO) Rating Reaffirmed Peel Hunt now has a GBX 935.00 target price on the 8.31B GBP market cap company or 8.59 % upside potential. In analysts note shared with investors and clients on Wednesday morning, Antofagasta PLC (LON:ANTO) shares have had their Hold Rating kept by equity research […]
Analysts expect Surface Oncology, Inc. (NASDAQ:SURF) to report $-0.62 EPS on August, 13.They anticipate $0.11 EPS change or 15.07 % from last quarter’s $-0.73 EPS. After having $-0.15 EPS previously, Surface Oncology, Inc.’s analysts see 313.33 % EPS growth. The stock decreased 1.90% or $0.05 during the last trading session, […]
Analysts expect Motus GI Holdings, Inc. (NASDAQ:MOTS) to report $-0.30 EPS on August, 13.They anticipate $0.03 EPS change or 11.11 % from last quarter’s $-0.27 EPS. After having $-0.29 EPS previously, Motus GI Holdings, Inc.’s analysts see 3.45 % EPS growth. The stock decreased 4.75% or $0.15 during the last […]
Analysts expect Iterum Therapeutics plc (NASDAQ:ITRM) to report $-1.62 EPS on August, 13.They anticipate $0.60 EPS change or 27.03 % from last quarter’s $-2.22 EPS. After having $-1.44 EPS previously, Iterum Therapeutics plc’s analysts see 12.50 % EPS growth. The stock decreased 2.08% or $0.14 during the last trading session, […]
Investors sentiment increased to 1.29 in 2019 Q1. Its up 0.06, from 1.23 in 2018Q4. It increased, as 9 investors sold InnerWorkings, Inc. shares while 26 reduced holdings. 17 funds opened positions while 28 raised stakes. 42.12 million shares or 6.64% more from 39.50 million shares in 2018Q4 were reported. […]
Analysts expect GDS Holdings Limited (NASDAQ:GDS) to report $-0.12 EPS on August, 13.They anticipate $0.00 EPS change or 0.00 % from last quarter’s $-0.12 EPS. After having $-0.18 EPS previously, GDS Holdings Limited’s analysts see -33.33 % EPS growth. The stock increased 3.26% or $1.22 during the last trading session, […]
Analysts expect CEL-SCI Corporation (NYSEAMERICAN:CVM) to report $-0.10 EPS on August, 13.They anticipate $0.26 EPS change or 72.22 % from last quarter’s $-0.36 EPS. After having $-0.19 EPS previously, CEL-SCI Corporation’s analysts see -47.37 % EPS growth. The stock decreased 4.50% or $0.39 during the last trading session, reaching $8.28. […]
Analysts expect Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) to report $-0.06 EPS on August, 13.After having $-0.20 EPS previously, Citius Pharmaceuticals, Inc.’s analysts see -70.00 % EPS growth. The stock decreased 0.49% or $0.005 during the last trading session, reaching $1.015. About 26,905 shares traded. Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) has declined 53.59% […]
